Appeal court reinstates Apple Watch ban
Apple has been banned from selling current versions of its Apple Watch in the US as a federal appeals court decides on the patent dispute regarding a sensor. This suggests that the company may pull the watches from stores for the second time in less than a month.
Medical technology company Masimo asserts that the watch's blood oxygen sensor infringes on its patents. In October the US International Trade Commission found that the Apple Watch Series 2 and Apple Watch Ultra 2 infringed on the patents and banned their import.
The ruling by the US court of Appeals in Washington comes just three weeks after it blocked the ban. The ITC decision will not apply to watches that have been redesigned to not include the blood oxygen monitoring element.
Source: www.tradingview.com
Apple (AAPL.us) has pulled back in recent weeks after reacting off key resistance at the $200 level. Since then, the stock has fallen from its bullish zone, between the upper blue and red bands, to its neutral area, between the blue bands. Its RSI has also dropped below 50 (green rectangle), into the bearish momentum region. If it maintains on this side, the stock price will remain under pressure.
Image by ErikaWittlieb from Pixabay
Russell Shor
Senior Market Strategist
Russell Shor is a Senior Market Strategist at FXCM, having been promoted to the role in 2025 in recognition of his depth of insight and consistent delivery of high-impact market analysis. He originally joined FXCM in October 2017 as a Senior Market Specialist.
Russell holds an Honours Degree in Economics from the University of South Africa, is a certified FMVA®, and a full member of the Society of Technical Analysts (UK). With over 20 years of experience in financial markets, his work is renowned for its clarity, precision, and strategic value across asset classes.
Any opinions, news, research, analyses, prices, other information, or links to third-party sites contained on this website are provided on an "as-is" basis, as general market commentary and do not constitute investment advice. The market commentary has not been prepared in accordance with legal requirements designed to promote the independence of investment research, and it is therefore not subject to any prohibition on dealing ahead of dissemination. Although this commentary is not produced by an independent source, FXCM takes all sufficient steps to eliminate or prevent any conflicts of interests arising out of the production and dissemination of this communication. The employees of FXCM commit to acting in the clients' best interests and represent their views without misleading, deceiving, or otherwise impairing the clients' ability to make informed investment decisions. For more information about the FXCM's internal organizational and administrative arrangements for the prevention of conflicts, please refer to the Firms' Managing Conflicts Policy. Please ensure that you read and understand our Full Disclaimer and Liability provision concerning the foregoing Information, which can be accessed here.